CHINA BIOMARKETING STRATEGY - BioPlan Associates€¦ · China. Our China team has expertise in...

2
Biopharma China is growing at over 15% annually. Chinese labs and biologics producers are contracting for your company’s products and solutions! Demand for life sciences products has never been higher. Budgets are growing for biotech materials, equipment and services. Bioplan can help get your products and services into the 2nd largest global market! associates, inc. 2275 Research Blvd, Suite 500, Rockville, MD 20850 | www.bioplanassociates.com | For Information: e-mail info@bioplanassociates or call +1–301–921–5979 WHY YOU NEED A CHINA GO-TO MARKET STRATEGY China’s biopharma market opportunities are growing Regulatory environment is rapidly developing Intellectual Property development The window of opportunity in this dynamic environment is open Challenges still exist and require a clear go-to-market strategy CHINA’S BIOPHARMA OPPORTUNITIES World’s largest population, rapidly growing economy Suppliers actively developing relationships in China today China’s Biopharma markets, growing steadily at 13% annually Demand for raw materials and equipment increasing at 20% Demand for services increasing rapidly CHINA BIOTECH STRATEGIC MARKETING SERVICES: SUCCESSFUL PRODUCT LAUNCH: Market research and analysis, distributor management, marketing strategy development; over 27 years' global experience to help ensure your products and services are effectively marketed in China. Analysis of your market potential in China and Asia; risk assessment, pricing, and messaging strategy. Distributor support services to identify and screen the best distributors. BioPlan’s t eam of experienced Chinese life sciences market analysts and distributor managers will help you develop successful long-term business opportunities. MARKET RESEARCH: Assess and quantify markets for your technologies in China. Our China team has expertise in conducting market research in China, with a focus on biopharma. Over the past decade, we have extensively researched and published studies, directories and analyses of China’s markets, including which bioprocessing technologies China’s markets need now. CHINA GO-TO-MARKET STRATEGY: Strategic analysis through market intelligence, lead development, distributor management, and strategy development. STRATEGIC INSIGHTS: Perspectives to determine your products’ success; strategic marketing, effective regional pricing strategies, messaging, and competitive positioning. ON-SITE MARKET ANALYSTS: Management experts and researchers in China to quickly assess your market situation and opportunities, including market research, lead generation, marketing support, translation, web design. RISK ASSESSMENT: Identify risks of doing business in China and recommend approaches to control them. China is the second largest global pharma market! CHINA BIOMARKETING STRATEGY Why you need a China Go-to Market Strategy WHY BIOPLAN?: With 27 years’ global experience, our expert staff in China provides a global network of experts to support your biotech strategic marketing, distributor management, and global market research needs.

Transcript of CHINA BIOMARKETING STRATEGY - BioPlan Associates€¦ · China. Our China team has expertise in...

Page 1: CHINA BIOMARKETING STRATEGY - BioPlan Associates€¦ · China. Our China team has expertise in conducting market research in China, with a focus on biopharma. Over the past decade,

Biopharma China is growing at over 15% annually. Chinese labs and biologics producers are contracting for your company’s products and solutions! Demand for life sciences products has never been higher. Budgets are growing for biotech materials, equipment and services. Bioplan can help get your products and services into the 2nd largest global market!

associates, inc.

2275 Research Blvd, Suite 500, Rockville, MD 20850 | www.bioplanassociates.com | For Information: e-mail info@bioplanassociates or call +1–301–921–5979

WHY YOU NEED A CHINA GO-TO MARKET STRATEGY

● China’s biopharma market opportunities are growing

● Regulatory environment is rapidly developing

● Intellectual Property development● The window of opportunity in this

dynamic environment is open● Challenges still exist and require a

clear go-to-market strategy

CHINA’S BIOPHARMA OPPORTUNITIES

● World’s largest population, rapidly growing economy

● Suppliers actively developing relationships in China today

● China’s Biopharma markets, growing steadily at 13% annually

● Demand for raw materials and equipment increasing at 20%

● Demand for services increasing rapidly

CHINA BIOTECH STRATEGIC MARKETING SERVICES:

● SUCCESSFUL PRODUCT LAUNCH: Market research and analysis, distributor management, marketing strategy development; over 27 years' global experience to help ensure your products and services are effectively marketed in China. Analysis of your market potential in China and Asia; risk assessment, pricing, and messaging strategy. Distributor support services to identify and screen the best distributors. BioPlan’s team of experienced Chinese life sciences market analysts and distributor managers will help you develop successful long-term business opportunities.

● MARKET RESEARCH: Assess and quantify markets for your technologies in China. Our China team has expertise in conducting market research in China, with a focus on biopharma. Over the past decade, we have extensively researched and published studies, directories and analyses of China’s markets, including which bioprocessing technologies China’s markets need now.

● CHINA GO-TO-MARKET STRATEGY: Strategic analysis through market intelligence, lead development, distributor management, and strategy development.

● STRATEGIC INSIGHTS: Perspectives to determine your products’ success; strategic marketing, effective regional pricing strategies, messaging, and competitive positioning.

● ON-SITE MARKET ANALYSTS: Management experts and researchers in China to quickly assess your market situation and opportunities, including market research, lead generation, marketing support, translation, web design.

● RISK ASSESSMENT: Identify risks of doing business in China and recommend approaches to control them.

China is the second largest global

pharma market!

CHINA BIOMARKETING STRATEGY Why you need a China Go-to Market Strategy

WHY BIOPLAN?: With 27 years’ global experience, our expert staff in China provides a global network of experts to support your biotech strategic marketing, distributor management, and global market research needs.

Page 2: CHINA BIOMARKETING STRATEGY - BioPlan Associates€¦ · China. Our China team has expertise in conducting market research in China, with a focus on biopharma. Over the past decade,

CONTACT USFOR MORE

INFORMATION

BioPlan Associates, Inc. 2275 Research Blvd, Suite 500 Rockville, MD 20850 USA +1 301-921-5979www.bioplanassociates.com [email protected]

BioPlan Associates, ChinaRoom 309, No.8 XiaoyunLi, Chaoyang District, Beijing, [email protected]

associates, inc.

2275 Research Blvd, Suite 500, Rockville, MD 20850 | www.bioplanassociates.com | For Information: e-mail info@bioplanassociates or call +1–301–921–5979

● EXPERIENCED: Our China Team has over two decades experience working with Chinese and Western companies in distributor management and market analysis in biopharma and life sciences.

● KNOWLEDGEABLE: Experience with identifying potential distributors, interviewing, and evaluating expertise, locating strengths and weaknesses. We identify distributors that fit your products.

● INSIGHTFUL: We know China distributors, reputations, and find distributors appropriate for your products, technologies, objectives and business philosophy.

● CULTURAL KNOWLEDGE: We understand the differences in business culture and build bridges for both parties.

● UNDERSTANDING MARKET NEEDS: Decades extensive market research experience, and expertise in China’s biotech, lab, and bioprocessing markets. We identify niche markets and define un-met needs.

● MARKET RESEARCH PROJECTS: Successfully conducted 100s of projects over the past 27 years for equipment/consumable suppliers.

● Find the Best China Distributor for your products and services● Develop Your Best Practices Roadmap: from China biotech experts who’ve sold in China

for years● Distributor Management Services: Insights and support to manage your China

representatives; local support will optimize your relationship● Managerial, and cultural advice: from experts with decades of experience in China.● IP and Legal: Recommend experts who can support your IP and legal concerns

MANAGEMENT SUPPORT: Distributor management in China, as your local representative. Incentivize and manage your distributors, simplify communications, evaluate distributors’ perfor-mance, manage change of distributors, if necessary.

RELATIONSHIP MAINTENANCE: As your representative, we build and maintain good relation-ships, explain your needs to your Chinese distributors, and give timely support and feedback to head off misunderstandings.

BACKUP PLANS: We develop back-up plans, identify alternatives to adjust strategy, if needed.

Production has grown 13.08%

annually to $227 Billion in 2016.

CHINA DISTRIBUTOR SERVICE

DISTRIBUTOR EVALUATION: Identify your best partner in China; with 100s of qualified distributors for medical, bioprocess, and biotech products, our on-the-ground experts assess distributors, and verify competence to represent your products effectively.

WHY CHOOSE BIOPLAN AS YOUR CHINA BUSINESS SOLUTIONS PARTNER